ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Income from Continuing Operations of 1311433.0 for Q1 2026, down 26.55% year-over-year from 1785377.24 in Q1 2025, and up 58.62% quarter-over-quarter from 3169209.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Income from Continuing Operations (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Income from Continuing Operations data on file, last reported at 1311433.0 in Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 1311433.0, down 26.55% year-over-year; the trailing twelve-month figure through Mar 2026 was 7302513.0 (up 25.24% YoY), and the FY2025 annual result was 7027410.0, up 38.93% from the prior year.
- Income from Continuing Operations advanced to 1311433.0 in Q1 2026 per NDRA's latest filing, from 3169209.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 1036330.0 in Q1 2025 and troughed at 4149004.0 in Q4 2024.
- A 5-year average of 2534478.35 and a median of 2775700.0 in 2024 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations tumbled 184.27% in 2024, then jumped 62.66% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 3289596.0 in 2022, then surged by 55.63% to 1459536.0 in 2023, then plunged by 184.27% to 4149004.0 in 2024, then increased by 23.62% to 3169209.0 in 2025, then soared by 58.62% to 1311433.0 in 2026.
- Business Quant data shows NDRA's Income from Continuing Operations at 1311433.0 in Q1 2026, 3169209.0 in Q4 2025, and 1595959.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -72.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 1.66 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 278.45 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 339.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 269.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -85.11 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 134.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 169.45 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | -1.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.31 Mn |
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.23 Mn |
| Mar 31, 2025 | -1.04 Mn |
| Dec 31, 2024 | -4.15 Mn |
| Sep 30, 2024 | -2.35 Mn |
| Jun 30, 2024 | -2.23 Mn |
| Mar 31, 2024 | -2.78 Mn |
| Dec 31, 2023 | -1.46 Mn |
| Sep 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -2.56 Mn |
| Mar 31, 2023 | -2.94 Mn |
| Dec 31, 2022 | -3.29 Mn |
| Sep 30, 2022 | -3.44 Mn |
| Jun 30, 2022 | -3.59 Mn |
| Mar 31, 2022 | -2.86 Mn |
| Dec 31, 2021 | -3.10 Mn |
| Sep 30, 2021 | -2.66 Mn |
| Jun 30, 2021 | -3.20 Mn |